Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1330537

registered interest
date	08/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	What recent assessment he has made of the progress of the covid-19 vaccine rollout programme across the UK.
tabling member constituency	Stoke-on-Trent North
tabling member printed	Jonathan Gullis
uin	900838
answer	answer is ministerial correction date of answer 08/06/2021 answer text <p>We have administered over 60 million vaccine jabs in the United Kingdom, with 75% of the adult population already having received their first dose. Over 25 million people have now received their second dose and</p><p>53% of people aged 30 to 39 years have received at least one dose since the programme began opening up to the age group on 13 May. This week, we will open the vaccination programme to ages 25 to 29 years old.</p><p>We are on track to meet our vaccination target to offer all adults a vaccine by the end of July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/06/2021 16:30:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4814 label Biography information for Jonathan Gullis

1328925

registered interest
date	27/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the efficacy of vaccination in preventing (a) transmission, (b) hospitalisation and (c) death arising from the B.1.617.2 variant of covid-19.
tabling member constituency	Forest of Dean
tabling member printed	Mr Mark Harper
uin	8562
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>Public Health England (PHE) has published early estimates of vaccine effectiveness against symptomatic disease with the B.1.617.2 variant which are available at the following link:</p><p><a href="https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1</a></p><p>The number of hospitalised cases and deaths from the B.1.617.2 variant of COVID-19 are currently too small to estimate vaccine effectiveness against these outcomes. PHE will continue to monitor the impact of the COVID-19 vaccines on variant B.1.617.2.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/06/2021 15:51:17 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1520 label Biography information for Mr Mark Harper

1328985

registered interest
date	27/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether clinically extremely vulnerable children under 16 should be able to access covid-19 vaccines; and how many clinically extremely vulnerable children are still shielding because they do not have access to that vaccine.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	8628
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>Children under 16 years of age, even if they are clinically extremely vulnerable (CEV), are at low risk of serious morbidity and mortality from COVID-19. There is also a lack of safety and efficacy data for COVID-19 vaccines in children. Most children under the age of 16, including those who are CEV, are therefore not recommended for routine vaccination.</p><p>Given the very high risk of exposure to infection and outbreaks in residential settings, vaccination may be appropriate for those with severe neuro-disabilities who require frequent care in these settings. This option should be discussed between parents or guardians and the child’s clinician.</p><p>As of 1 April, due to low prevalence, shielding advice has been paused for all clinically extremely vulnerable people, including children and young people. All CEV pupils should attend their school unless they are one of the very small number of pupils under paediatric or other specialist care and have been advised by their GP or clinician not to attend. Pupils who live with someone who is CEV should continue to attend school as normal.</p><p>More information on children and COVID-19 vaccination can be found at the following link: <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984310/Greenbook_chapter_14a_7May2021.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984310/Greenbook_chapter_14a_7May2021.pdf</a></p><p>Current guidance to individuals who are clinically extremely vulnerable, including children, can be found at the following link: <a href="https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19" target="_blank">https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/06/2021 15:54:49 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford

1329010

registered interest
date	27/05/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Iron and Steel: Safeguard Measures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with the Secretary of State for International Trade on the (a) Trade Remedies Investigations Directorate's Statement of Intended Final Determination published on 19 May 2021 and (b) impact of that statement on the economic and public interests of the UK.
tabling member constituency	Feltham and Heston
tabling member printed	Seema Malhotra
uin	8606
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>BEIS Ministers and officials have regular discussions with their counterparts in the Department for International Trade on a range of issues of mutual interest, including on trade and steel.</p><p>The Trade Remedies Authority (TRA) will make a final recommendation before the UK steel safeguard measures are due to expire on 30 June 2021. My Rt. Hon. Friend the Secretary of State for International Trade may only reject a recommendation to impose a measure if she considers that it is not in the public interest or that the economic interest test has not been met. If this happens, the Secretary of State must lay down her reasons to Parliament.</p><p>She can accept or reject a TRA recommendation as a whole but not modify or partially accept it. She cannot extend a measure if the TRA does not recommend this.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/06/2021 16:11:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4253 label Biography information for Seema Malhotra

1329011

registered interest
date	27/05/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Iron and Steel: Safeguard Measures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with the Secretary of State for International Trade on extending the UK’s steel safeguards beyond the expiry date of 30 June 2021.
tabling member constituency	Feltham and Heston
tabling member printed	Seema Malhotra
uin	8607
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>BEIS Ministers and officials have regular discussions with their counterparts in the Department for International Trade on a range of issues of mutual interest, including on trade and steel. The Trade Remedies Authority (TRA) will make a recommendation on whether to extend or revoke the UK steel safeguard measures which are due to expire on 30 June 2021. My Rt. Hon. Friend the Secretary of State for International Trade can either accept or reject the recommendation as a whole, but not modify or partially accept it. She cannot extend the measures if the TRA does not recommend this.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 8608 question first answered 07/06/2021 16:12:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4253 label Biography information for Seema Malhotra

1329012

registered interest
date	27/05/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Iron and Steel: Safeguard Measures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the impact on the steel industry of not extending the UK’s current steel safeguards beyond the expiry date of 30 June 2021.
tabling member constituency	Feltham and Heston
tabling member printed	Seema Malhotra
uin	8608
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>BEIS Ministers and officials have regular discussions with their counterparts in the Department for International Trade on a range of issues of mutual interest, including on trade and steel. The Trade Remedies Authority (TRA) will make a recommendation on whether to extend or revoke the UK steel safeguard measures which are due to expire on 30 June 2021. My Rt. Hon. Friend the Secretary of State for International Trade can either accept or reject the recommendation as a whole, but not modify or partially accept it. She cannot extend the measures if the TRA does not recommend this.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 8607 question first answered 07/06/2021 16:12:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4253 label Biography information for Seema Malhotra

1328107

registered interest
date	26/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that students studying abroad in the 2021-22 academic year will have received their covid-19 vaccinations before travelling.
tabling member constituency	Coventry South
tabling member printed	Zarah Sultana
uin	7954
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>There are currently no plans to prioritise students specifically as a group. This includes those studying abroad next academic year. Students aged 18 years old and over are prioritised on grounds of age in phase two of the COVID-19 vaccine programme if they have not been vaccinated as part of phase one. Phase two offers vaccination to all those aged 18 to 49 years old unless they fall into a higher cohort group due to age or pre-existing health condition which puts them in phase one.</p><p> </p><p>The Government is working closely with the devolved administrations, the higher education sector and health services across the United Kingdom to ensure that all students are able to access the vaccine efficiently and conveniently where they are eligible. The Government advises those who may be unable to receive a full course of vaccination in the UK to notify clinicians of this before they receive their vaccination. For any foreign travel, the Government advises checking GOV.UK for relevant information including information on healthcare provision.</p><p> </p><p>We are on track to offer a first dose of COVID-19 vaccination to all those aged 18 years old and over by 31 July.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/06/2021 15:56:28 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4786 label Biography information for Zarah Sultana

1328262

registered interest
date	26/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to assess the potential merits of covid-19 vaccine boosters for (a) people with blood cancer and (b) other people who are immunocompromised.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	7732
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>To ensure ongoing protection for the United Kingdom’s population, particularly the most vulnerable, we are preparing for a potential booster vaccination programme. Whilst we are planning for several potential scenarios, final decisions on the timing and scope of the booster programme in terms of when to give boosters to which groups and with which vaccines will not be taken until later this year, in line with results from key clinical studies. Any decision on a booster vaccination programme will be informed by independent advice from the Joint Committee for Vaccination and Immunisation (JCVI).</p><p>As part of the National Core Studies Immunity Programme (NCSi), UK Research and Innovation (UKRI) is providing initial funding of £1.8 million for 12 months towards the OCTAVE study. The OCTAVE study will examine the effectiveness of COVID-19 vaccines in clinically at-risk groups and will help to inform planning for the booster programme. This includes COVID-19 vaccine responses in patients with certain immunosuppressed conditions, including those with inflammatory disorders, high risk cancer patient groups, blood cancer patients and patients with severe kidney and liver disease. Cancer patient groups include those with blood cancer (leukaemia, myeloma, and bone marrow (stem cell) transplants).</p><p>Studies into the specific effect of a COVID-19 booster vaccine on certain groups have not yet been established. However, as part of the NCSi, UKRI is providing £3 million in funding towards a new research call to support projects examining one or both of the following areas - the nature and quality of COVID-19 vaccine responses, the mechanisms of immune failure that lead to either COVID-19 re-infection or vaccine breakthrough. As the nation's largest funder of health and care research, the NIHR welcomes funding applications for research into any aspect of human health, including on COVID-19 vaccination and immunocompromised individuals.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/06/2021 15:50:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	394 label Biography information for Mr Clive Betts

1327693

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of using community development centres to help promote and administer the covid19 vaccine in areas where the take-up of the vaccine is lower than average.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	7178
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>The delivery of the vaccination programme is designed to be convenient and flexible, including in areas where there are groups with lower uptake. There is already a wide offer of vaccination settings such as religious and community centres. Local and national public health agencies are consulted on how best to utilise this flexibility to maximise uptake in groups with low vaccine uptake.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 03/06/2021 16:41:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1327749

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps is he taking to measure the value of covid-19 vaccine boosters for (a) people with blood cancer and (b) other immunocompromised groups.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	7194
answer	answer is ministerial correction date of answer 02/06/2021 answer text <p>To ensure ongoing protection for the United Kingdom population, particularly the most vulnerable, we are preparing for a potential booster vaccination programme. While we are planning for several potential scenarios, final decisions on the timing and scope of the booster programme will not be taken until later this year, in line with results from key clinical studies. This includes the OCTAVE study, which will examine the effectiveness of COVID-19 vaccines in clinically at-risk groups, including patients with certain immunocompromised conditions such as blood cancer.</p><p>Any decision on a booster vaccination programme will be informed by independent advice from the Joint Committee for Vaccination and Immunisation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 02/06/2021 16:21:59 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4370 label Biography information for Jess Phillips